Nasdaq Jspr News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Jasper Therapeutics (NASDAQ:JSPR – Get Free Report) and Evaxion Biotech A/S (NASDAQ:EVAX – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, dividends, profitability, analyst recommendations, valuation, earnings and risk. Profitability This table compares Jasper Therapeutics […]

Investment analysts at Evercore ISI assumed coverage on shares of Jasper Therapeutics (NASDAQ:JSPR – Get Free Report) in a note issued to investors on Wednesday, Marketbeat.com reports. The brokerage set an “outperform” rating and a $65.00 price target on the stock. Evercore ISI’s price target would indicate a potential upside of 136.02% from the stock’s […]

Jasper Therapeutics, Inc. (NASDAQ:JSPR – Get Free Report) was the recipient of a large growth in short interest in the month of January. As of January 31st, there was short interest totalling 276,200 shares, a growth of 43.5% from the January 15th total of 192,500 shares. Based on an average daily volume of 109,400 shares, […]

REDWOOD CITY, Calif., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a biotechnology company focused on...

Jasper Therapeutics, Inc. (NASDAQ:JSPR – Get Free Report) was the recipient of a large decrease in short interest during the month of December. As of December 31st, there was short interest totalling 184,300 shares, a decrease of 90.4% from the December 15th total of 1,910,000 shares. Currently, 2.3% of the shares of the company are […]